Cargando…
Within-subject, double-blind, randomized, placebo-controlled evaluation of combining the cannabinoid dronabinol and the opioid hydromorphone in adults with chronic pain
The potential synergistic effects of combining cannabinoids and opioids for analgesia has received considerable attention. No studies to date have evaluated this combination in patients with chronic pain. The present study aimed to evaluate the combined analgesic and drug effects of oral opioid (hyd...
Autores principales: | Campbell, Claudia M., Mun, Chung Jung, Hamilton, Katrina R., Bergeria, Cecilia L., Huhn, Andrew S., Speed, Traci J., Vandrey, Ryan, Dunn, Kelly E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516978/ https://www.ncbi.nlm.nih.gov/pubmed/37202479 http://dx.doi.org/10.1038/s41386-023-01597-1 |
Ejemplares similares
-
Within-subject, double-blinded, randomized, and placebo-controlled evaluation of the combined effects of the cannabinoid dronabinol and the opioid hydromorphone in a human laboratory pain model
por: Dunn, Kelly E., et al.
Publicado: (2021) -
Within subject, double blind, examination of opioid sensitivity in participant-reported, observed, physiologic, and analgesic outcomes
por: Durgin, Caitlyn J., et al.
Publicado: (2023) -
Evaluation of Stigma Related to Perceived Risk for Coronavirus-19 Transmission Relative to the Other Stigmatized Conditions Opioid Use and Depression
por: Okobi, Sandra, et al.
Publicado: (2022) -
Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
por: Parikh, Neha, et al.
Publicado: (2016) -
Operational definition of precipitated opioid withdrawal
por: Dunn, Kelly E., et al.
Publicado: (2023)